for dual antiplatelet therapy, 1.83 (95% CI, 1.72–1.96) for warfarin plus aspirin, 3.08 (95% CI, 2.32–3.91) for warfarin plus clopidogrel, and 3.70 (95% CI, 2.89–4.76) for triple therapy.

Overall, triple antithrombotic therapy with the addition of warfarin to dual antiplatelet therapy did not reduce the risk of reinfarction in patients undergoing primary PCI and did increase the ...